News | December 30, 2013

RaySearch, TomoTherapy Cancel License Agreement

December 30, 2013 — RaySearch Laboratories and TomoTherapy Inc. (now Accuray) entered a software licensing and development agreement in 2007, under which RaySearch developed a product named SharePlan. TomoTherapy launched Shareplan in 2009.
 
SharePlan is a treatment planning solution that enables transfer of treatment plans between TomoTherapy systems and conventional linear accelerators. The product uses algorithms to automatically generate a selection of deliverable intensity-modulated radiation therapy (IMRT) plans based on an existing TomoTherapy treatment plan. This time-saving concept is a tool for optimizing patient benefit and throughput at clinics that have a mixed environment with both TomoTherapy systems and conventional linear accelerators.
 
Now RaySearch and Accuray have agreed to cancel the agreement and end the partnership. SharePlan functionality will continue to be available for new and existing customers as an integrated module in RaySearch’s RayStation treatment planning system that is sold and marketed by RaySearch. Existing SharePlan customers will be offered a free upgrade to RayStation.
 
“Since the original agreement was signed, a lot has changed for both companies, so this solution makes good sense for both parties,” said Johan Löf, CEO, RaySearch. “RayStation was not available four years ago, so back then a stand-alone application was the best solution. Now however, we can offer the same functionality in RayStation, which is evolving very rapidly and also gives the TomoTherapy System users the option to select other features and advanced treatment planning tools. This is attractive for the customers and Accuray alike, as it expands the product offering for these customers.”
 

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation